| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Secretary | CFO, Chief Bus. Off. And Secy. | Chief Business Officer
2 companies
Levy Adam Scott serves as a Chief Business Officer at VRDN and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 23 sells. Those positions are worth an estimated $336K at current prices.
Historically, Levy Adam Scott's trades have earned a below-average insider score of 35/100 across 13 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -70.9%.
The biggest single holding is MLYS (~$278K) as CFO And Secretary. The recent filings there lean toward selling, a net 359,069 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,758 | $32.14 | $345,723.39 | -55.5% | -19.3% | - | |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sale+OE | 119,524 | $44.88 | $5,363,715.88 | -86.0% | -32.6% | - | |
| Oct 13, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,758 | $42.01 | $451,983.56 | -8.4% | -23.4% | - | |
| Jul 30, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 73,678 | $14.62 | $1,077,476.77 | -35.7% | +180.7% | +80.7% | |
| Jul 11, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,758 | $14.45 | $155,454.18 | -4.9% | +171.8% | +95.9% | |
| Apr 11, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,757 | $12.06 | $129,684.24 | -4.8% | +9.3% | +98.7% | |
| Jan 13, 2025 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,757 | $9.10 | $97,863.90 | -4.5% | +48.7% | +251.9% | |
| Oct 11, 2024 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,757 | $13.57 | $146,003.69 | -4.3% | -27.2% | +210.9% | |
| Jul 11, 2024 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 10,757 | $13.14 | $141,394.31 | -4.2% | +1.0% | +6.8% | |
| Jun 11, 2024 | MLYS Mineralys Therapeutics, Inc. | CFO And Secretary | Sell | 96,815 | $12.94 | $1,252,718.33 | -27.5% | -8.9% | +19.7% |